CC Uphoff

764 total citations
12 papers, 586 citations indexed

About

CC Uphoff is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, CC Uphoff has authored 12 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in CC Uphoff's work include Acute Myeloid Leukemia Research (6 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Acute Lymphoblastic Leukemia research (3 papers). CC Uphoff is often cited by papers focused on Acute Myeloid Leukemia Research (6 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Acute Lymphoblastic Leukemia research (3 papers). CC Uphoff collaborates with scholars based in Germany, Japan and Italy. CC Uphoff's co-authors include HG Drexler, H. Drexler, Antonino Carbone, Gianluca Gaïdano, Yoshinobu Matsuo, Eijiro Omoto, M Harada, K Orita, Yoshio Katayama and C Nishizaki and has published in prestigious journals such as Blood and Leukemia.

In The Last Decade

CC Uphoff

12 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
CC Uphoff Germany 9 234 193 172 142 114 12 586
HG Drexler Germany 12 326 1.4× 227 1.2× 187 1.1× 191 1.3× 115 1.0× 15 712
H G Drexler Germany 17 318 1.4× 153 0.8× 324 1.9× 216 1.5× 127 1.1× 26 810
Corinne Millien France 11 144 0.6× 79 0.4× 106 0.6× 136 1.0× 83 0.7× 15 472
T Onuma Japan 4 206 0.9× 165 0.9× 217 1.3× 365 2.6× 54 0.5× 4 784
Masami Nagai Japan 18 349 1.5× 224 1.2× 299 1.7× 79 0.6× 165 1.4× 64 835
Daniela Werth Germany 9 246 1.1× 221 1.1× 63 0.4× 338 2.4× 34 0.3× 12 659
Kathy S. Wang United States 9 126 0.5× 168 0.9× 125 0.7× 360 2.5× 47 0.4× 11 588
O Asai Japan 11 117 0.5× 135 0.7× 281 1.6× 436 3.1× 65 0.6× 17 726
Andrea Arruda Canada 10 188 0.8× 163 0.8× 159 0.9× 255 1.8× 23 0.2× 39 566
Boris Brill Germany 15 266 1.1× 183 0.9× 108 0.6× 177 1.2× 43 0.4× 33 578

Countries citing papers authored by CC Uphoff

Since Specialization
Citations

This map shows the geographic impact of CC Uphoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CC Uphoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CC Uphoff more than expected).

Fields of papers citing papers by CC Uphoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by CC Uphoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CC Uphoff. The network helps show where CC Uphoff may publish in the future.

Co-authorship network of co-authors of CC Uphoff

This figure shows the co-authorship network connecting the top 25 collaborators of CC Uphoff. A scholar is included among the top collaborators of CC Uphoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with CC Uphoff. CC Uphoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Uphoff, CC, Claus Meyer, & HG Drexler. (2002). Elimination of mycoplasma from leukemia–lymphoma cell lines using antibiotics. Leukemia. 16(2). 284–288. 28 indexed citations
2.
Uphoff, CC & HG Drexler. (2002). Detection of mycoplasma in leukemia–lymphoma cell lines using polymerase chain reaction. Leukemia. 16(2). 289–293. 62 indexed citations
3.
Drexler, H., et al.. (2000). p53 alterations in human leukemia–lymphoma cell lines: in vitroartifact or prerequisite for cell immortalization?. Leukemia. 14(1). 198–206. 41 indexed citations
4.
5.
Uphoff, CC, et al.. (1998). HHV-8 infection is specific for cell lines derived from primary effusion (body cavity-based) lymphomas. Leukemia. 12(11). 1806–1809. 28 indexed citations
6.
Uphoff, CC, et al.. (1998). Lymphoma cell lines: in vitro models for the study of HHV-8+ primary effusion lymphomas (body cavity-based lymphomas). Leukemia. 12(10). 1507–1517. 97 indexed citations
7.
Uphoff, CC, et al.. (1997). Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in human early B-lineage leukemia cell lines. Leukemia. 11(3). 441–447. 66 indexed citations
9.
Ma, Weili, et al.. (1994). c-kit expression in human megakaryoblastic leukemia cell lines. Blood. 83(8). 2133–2144. 35 indexed citations
10.
Ma, Weili, et al.. (1994). c-kit expression in human megakaryoblastic leukemia cell lines. Blood. 83(8). 2133–2144. 1 indexed citations
11.
Ma, Weili, et al.. (1993). Myeloperoxidase: expression and modulation in a large panel of human leukemia-lymphoma cell lines. Blood. 82(5). 1599–1607. 33 indexed citations
12.
Ma, Weili, et al.. (1993). Myeloperoxidase: expression and modulation in a large panel of human leukemia-lymphoma cell lines. Blood. 82(5). 1599–1607. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026